Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pfizer Inc shares valued at $64,825 were sold by DAMICO JENNIFER B. on Mar 04 ’25. At $25.93 per share, DAMICO JENNIFER B. sold 2,500 shares. The insider’s holdings dropped to 11,850 shares worth approximately $0.3 million following the completion of this transaction.
Also, BLAYLOCK RONALD E purchased 19,457 shares, netting a total of over 499,072 in proceeds. Following the buying of shares at $25.65 each, the insider now holds 27,707 shares.
Before that, Gottlieb Scott had added 1,000 shares to its account. In a trade valued at $28,240, the Director bought Pfizer Inc shares for $28.24 each. Upon closing the transaction, the insider’s holdings increased to 1,000 shares, worth approximately $0.26 million.
Analysts at Wolfe Research started covering the stock with ‘”an Underperform”‘ outlook in a report released in mid November. Earlier on October 17, 2024, Bernstein initiated its rating. Their recommendation was “a Mkt perform” for PFE stock.
Analyzing PFE Stock Performance
During the last five days, there has been a drop of approximately -0.89%. Over the course of the year, Pfizer Inc shares have dropped approximately -3.09%. Shares of the company reached a 52-week high of $27.57 on 01/07/25 and a 52-week low of $25.17 on 02/12/25. A 50-day SMA is recorded $26.30, while a 200-day SMA reached $27.71.
Support And Resistance Levels for Pfizer Inc (PFE)
According to the 24-hour chart, there is a support level at 25.48, which, if violated, would cause prices to drop to 25.26. In the upper region, resistance lies at 25.95. The next price resistance is at 26.20. RSI (Relative Strength Index) is 44.06 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.16, which suggests the price will decrease in the coming days. Percent R is at 87.93%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
